Cargando…
Insulin resistance as a common clinical feature in diabetes mellitus, obesity, hypertension, dyslipidemia, and atherosclerosis deserves more attention in COVID-19
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607179/ https://www.ncbi.nlm.nih.gov/pubmed/34899936 http://dx.doi.org/10.4103/jrms.JRMS_1063_20 |
| _version_ | 1784602506986258432 |
|---|---|
| author | Mahrooz, Abdolkarim |
| author_facet | Mahrooz, Abdolkarim |
| author_sort | Mahrooz, Abdolkarim |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8607179 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86071792021-12-09 Insulin resistance as a common clinical feature in diabetes mellitus, obesity, hypertension, dyslipidemia, and atherosclerosis deserves more attention in COVID-19 Mahrooz, Abdolkarim J Res Med Sci Letter to Editor Wolters Kluwer - Medknow 2021-10-18 /pmc/articles/PMC8607179/ /pubmed/34899936 http://dx.doi.org/10.4103/jrms.JRMS_1063_20 Text en Copyright: © 2021 Journal of Research in Medical Sciences https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Letter to Editor Mahrooz, Abdolkarim Insulin resistance as a common clinical feature in diabetes mellitus, obesity, hypertension, dyslipidemia, and atherosclerosis deserves more attention in COVID-19 |
| title | Insulin resistance as a common clinical feature in diabetes mellitus, obesity, hypertension, dyslipidemia, and atherosclerosis deserves more attention in COVID-19 |
| title_full | Insulin resistance as a common clinical feature in diabetes mellitus, obesity, hypertension, dyslipidemia, and atherosclerosis deserves more attention in COVID-19 |
| title_fullStr | Insulin resistance as a common clinical feature in diabetes mellitus, obesity, hypertension, dyslipidemia, and atherosclerosis deserves more attention in COVID-19 |
| title_full_unstemmed | Insulin resistance as a common clinical feature in diabetes mellitus, obesity, hypertension, dyslipidemia, and atherosclerosis deserves more attention in COVID-19 |
| title_short | Insulin resistance as a common clinical feature in diabetes mellitus, obesity, hypertension, dyslipidemia, and atherosclerosis deserves more attention in COVID-19 |
| title_sort | insulin resistance as a common clinical feature in diabetes mellitus, obesity, hypertension, dyslipidemia, and atherosclerosis deserves more attention in covid-19 |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607179/ https://www.ncbi.nlm.nih.gov/pubmed/34899936 http://dx.doi.org/10.4103/jrms.JRMS_1063_20 |
| work_keys_str_mv | AT mahroozabdolkarim insulinresistanceasacommonclinicalfeatureindiabetesmellitusobesityhypertensiondyslipidemiaandatherosclerosisdeservesmoreattentionincovid19 |